ARS Pharmaceuticals
SPRY · NASDAQ
$4.29+$0.06 (+1.42%)TodayMarket closed ·
Prev close $4.23
Who owns SPRY
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 67.6% of SPRY’s shares.
- RA Capital Management, LP10.9%
- Lowenthal (Richard E)10.1%
- Rubric Capital Management LP8.6%
- OrbiMed Advisors, LLC8.3%
- Next 6 largest institutions29.5%
- All other shareholders32.4%
| Holder | Shares | % of shares |
|---|---|---|
| RA Capital Management, LP | 10.86M | 10.94% |
| Lowenthal (Richard E) | 10.06M | 10.13% |
| Rubric Capital Management LP | 8.54M | 8.60% |
| OrbiMed Advisors, LLC | 8.29M | 8.35% |
| Deerfield Management Company, L.P. | 7.50M | 7.56% |
| BlackRock Institutional Trust Company, N.A. | 4.71M | 4.74% |
| Pratik Shah Living Trust | 4.47M | 4.51% |
| Tyro Capital Management LLC | 4.46M | 4.49% |
| abrdn Inc. | 4.17M | 4.20% |
| SR One Capital Management, LP | 4.01M | 4.04% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| American Funds SMALLCAP World Fund | 2.68M | 2.70% |
| State Street SPDR S&P Biotech ETF | 2.41M | 2.43% |
| abrdn Healthcare Opportunities Fund | 1.78M | 1.80% |
| Vanguard Total Stock Market Index Fund | 1.75M | 1.76% |
| iShares Russell 2000 ETF | 1.60M | 1.61% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $283.55K (2 trades) of SPRY on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Casale Donn | Award | 1.04M | — |
| Smith Margaret Ekins | Award | 1.00M | — |
| Casale Donn | Award | 898.46K | — |
| Kelly Michael | Award | 30.00K | — |
| Dadoo Rajeev | Award | 30.00K | — |
| Shah Pratik | Award | 30.00K | — |
| Islam Saqib | Award | 30.00K | — |
| Shawver Laura | Award | 30.00K | — |
| Thompson Peter A. | Award | 30.00K | — |
| RA Capital Healthcare Fund LP | Award | 30.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 21.19M
- Days to cover
- 16.10
- % of shares outstanding
- 21.34%
- Average daily volume
- 1.32M
- Change since last report
- −8.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.